Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors.

MLA

Larson, Allison R., et al. “Loss of 5-Hydroxymethylcytosine Correlates with Increasing Morphologic Dysplasia in Melanocytic Tumors.” Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc, vol. 27, no. 7, July 2014, pp. 936–44. EBSCOhost, https://doi.org/10.1038/modpathol.2013.224.

APA

Larson, A. R., Dresser, K. A., Zhan, Q., Lezcano, C., Woda, B. A., Yosufi, B., Thompson, J. F., Scolyer, R. A., Mihm, M. C., Jr, Shi, Y. G., Murphy, G. F., & Lian, C. G. (2014). Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc, 27(7), 936–944. https://doi.org/10.1038/modpathol.2013.224

Chicago

Larson, Allison R, Karen A Dresser, Qian Zhan, Cecilia Lezcano, Bruce A Woda, Benafsha Yosufi, John F Thompson, et al. 2014. “Loss of 5-Hydroxymethylcytosine Correlates with Increasing Morphologic Dysplasia in Melanocytic Tumors.” Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc 27 (7): 936–44. doi:10.1038/modpathol.2013.224.